The costly failure of amyloid-beta drugs: A cautionary tale in pharmaceutical development
By
crescit_eundo
A five-star bake. Worth schmearing, sharing, saving.
Summary
The article discusses drug classes that are perceived as failures after massive investment and clinical trials, using amyloid-beta drugs for Alzheimer's as the primary example. It describes how these drugs consume billions of dollars and affect thousands of patients before being recognized as ineffective. The piece appears to be an opinionated analysis of pharmaceutical development failures, specifically focusing on the amyloid-beta drug class as a cautionary tale.
Key quotes
· 4 pulledThere exist drug classes that seem, in retrospect, cursed.
As these chemicals worm their way through the clinical trial system, they consume billions of dollars along the way, and squelch through thousands of sick patients.
When finally it dawns on everyone how useless the whole endeavour was, the drugs life is at last cut short, nothing useful left in its destructive wake.
These are Alzheimer's treatments that are widely perceived as immense disappointments, with the negative sentiment even leaking to the broader public.
You might also wanna read
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a
npr.org·10h ago
GeneSkin Develops mRNA Therapy Targeting Skin Stem Cells for Rejuvenation and Hair Growth
GeneSkin is developing a novel mRNA therapy targeting basal stem cells in the skin to address a wide range of dermatological issues includin
wyss.harvard.edu·12h ago
First human trial begins for drug that could regrow missing teeth
Kyoto University Hospital has launched the first human trial of TRG-035, a drug designed to regrow teeth in adults by blocking a protein tha
boingboing.net·1d ago
Japanese researchers develop vitamin K-like compounds that may help convert brain cells into neurons
Japanese researchers have developed a new family of vitamin K-like molecules that may help immature brain cells transition into neurons. Whi
zmescience.com·1d ago
International trial shows DNA test could help many breast cancer patients avoid chemotherapy
A new international trial presented at the American Society of Clinical Oncology conference suggests that millions of breast cancer patients
bbc.co.uk·1d ago
Cohort Study Evaluates Age at Onset and Family History as Predictors for Genetic Testing in Parkinson Disease
This cohort study evaluates the association between age at onset (AAO) and family history in Parkinson disease patients who carry pathogenic
doi.org·1d ago